CLINICAL_TRIALS
withdrawal
· 2018-03-07
Clinical Trial Update: Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating changes in 25-hydroxyvitamin D3 levels after Vitamin D3 supplementation has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Vitamin D Deficiency | Phase 1, Phase 2 | Status: WITHDRAWN